MorphoSys Targets 2020 Tafasitamab Launch Following Good DLBCL Data

 
• By Sten Stovall
  
Lymphoma
L-MIND Combined MOR208 And Lenalidomide In r/r DLBCL Patients • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D